CAMPFIRE: A Study of Abemaciclib (LY2835219) in Participants With Ewing's Sarcoma
Conditions: Sarcoma, Ewing; Neoplasm Metastasis Interventions: Drug: Abemaciclib; Drug: Irinotecan; Drug: Temozolomide Sponsor: Eli Lilly and Company Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - July 1, 2022 Category: Research Source Type: clinical trials